Skip to main content
. 2023 May 18;47(7):785–791. doi: 10.1097/PAS.0000000000002050

TABLE 3.

Sensitivity, Specificity, PPV, and NPV Scores for Patients With MEN1 and Non-MEN1 Syndrome-related Parathyroid Tumors

Aberrant tumors per patient (n) Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI)
All tumors 1 100 (79-100) 91 (75-98) 84 (60-97) 100 (88-100)
Single tumors 1 100 (63-100) 100 (81-100) 100 (63-100) 100 (81-100)
Multiple tumors 1 100 (63-100) 79 (49-95) 73 (39-94) 100 (72-100)
2 100 (63-100) 100 (77-100) 100 (63-100) 100 (77-100)
3 100 (48-100) 100 (66-100) 100 (48-100) 100 (66-100)